Effect of niacin on LXRα and PPARγ expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits

International Journal of Cardiology

Volumn 124, Issue 2, 2008, Pages 172-178

  Zhao, Shui ping ^a   Yang, Jun ^a   Li, Jing ^a   Dong, Shao zhuang ^a   Wu, Zhi hong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adipocyte; Hypercholesterolemia; Liver X receptors (LXR) ; Niacin; Peroxisome proliferator activated receptor (PPAR )

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR ALPHA; NICOTINIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; CELL RECEPTOR; CHOLESTEROL; DNA BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LIVER X RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADIPOCYTE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PROBABILITY; RANDOMIZATION; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSPORT AT THE CELLULAR LEVEL;

ADIPOCYTES; ANALYSIS OF VARIANCE; ANIMALS; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL TRANSPORT; CHOLESTEROL; CHOLESTEROL, HDL; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HYPERCHOLESTEROLEMIA; MALE; NIACIN; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROBABILITY; RABBITS; RANDOM ALLOCATION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 38649122697     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.12.032     Document Type: Article

References (33)

1. Berg A.H., and Scherer P.H. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96 (2005) 939-949
2. Barter P.J., and Rye K.A. Molecular mechanism of reverse cholesterol transport. Curr Opin Lipidol 7 (1996) 82-87
3. Rader D.J. Regulation of reverse cholesterol transport and clinical implications. Am J Cardiol 92 (2003) 42J-49J [suppl]
4. Tontonoz P., and Margesdorf D.J. Liver X receptor signaling pathway in cardiovascular disease. Mol Endocrinol 17 (2003) 985-993
5. Edwards P.A., Kennedy M.A., and Mak P.A. LXRs: oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul Pharmacol 38 (2002) 249-256
6. Tangirala R.K., Bischoff E.D., Joseph S.B., et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci U S A 99 (2002) 11896-11901
7. Chawla A., Boisvert W.A., Lee C.H., et al. A PPARγ-LXR-ABAC1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7 (2004) 161-171
8. Ricote M., Valledor A.F., and Glass CK. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 230-239
9. Chinetti G.S., Lestavel V., Bocher A.T., et al. PPAR-alpha and PPARgamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7 (2001) 53-58
10. Li A.C., and Glass C.K. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J Lipid Res 45 (2004) 2161-2173
11. Wang N., Ranalletta M., Matsuura F., et al. LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arterioscler Thromb Vasc Biol 26 (2006) 1310-1316
12. Mckenney J. New perspectives on the use of niacin in the treatment of lipid disorders. Arch Intern Med 164 (2004) 697-705
13. Taylor A.J., Sullenberger L.E., Lee H.J., et al. Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation 110 (2004) 3512-3517
14. Rubic T., Trottmann M., and Lorenz R.L. Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin. Biochem Pharmacol 67 (2004) 411-419
15. Rodbell M. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239 (1963) 375-380
16. Prattes S., Horl G., Hammer A., et al. Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: triglyceride droplets are surrounded by cholesterol-rich ER-like surface layer structures. J Cell Sci 113 (2000) 2977-2989
17. Tamura K., Chen Y.E., Horiuchi M., et al. LXRα functions as a cAMP-responsive transcriptional regulator of gene expression. Proc Natl Acad Sci U S A 97 (2000) 8513-8518
18. Willy P.J., Umesono K., Ong E.S., et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9 (1995) 1033-1045
19. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 30 (2004) 13-19
20. Arner P. Is familial combined hyperlipidaemia a genetic disorder of adipose tissue?. Curr Opin Lipidol 8 (1997) 89-94
21. Repa J.J., and Mangelsdorf D.J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol 16 (2000) 459-481
22. Zelcer N., and Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116 (2006) 607-614
23. Lewis G.F., and Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96 (2005) 1221-1232
24. Repa J.J. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 (2000) 1524-1529
25. Khovidhunkit W., Moser A.H., Shigenaga J.K., et al. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in j774 murine macrophages: differential role of LXR. J Lipid Res 44 (2003) 1728-1739
26. Borst P., and Elferink R.O. Mammalian ABC transporters in health and disease. Ann Rev Biochem 71 (2002) 537-592
27. Costet P., Luo Y., Wang N., et al. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275 (2000) 28240-28245
28. Repa J.J. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277 (2002) 18793-18800
29. Sabol S.L., Brewer H.B., and Santamarina-Fojo S. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J Lipid Res 46 (2005) 2151-2167
30. Brendel C., Schoonjans K., Botrugno O.A., et al. The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity. Mol Endocrinol 16 (2002) 2065-2076
31. Joseph S.B., and Tontonoz P. LXRs: new therapeutic targets in atherosclerosis?. Curr Opin Pharmacol 3 (2003) 192-197
32. Fitzgerald M.L., Moore K.J., and Freeman M.W. Nuclear hormone receptors and cholesterol trafficking: the orphans find a new home. J Mol Med 80 (2002) 271-281
33. Knowles H.J., Poole R.T., Workman P., et al. Niacin induces PPARγ expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways. Biochem Pharmacol 71 (2006) 646-656